Top compounds associated with response to TMEM63C


Feature Type Standardized
Nominal ANOVA
mRNA tivozanib CTRPv2 pan-cancer AAC 0.05 0.2
mRNA tosedostat CTRPv2 pan-cancer AAC 0.022 0.5
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.048 0.2
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.01 0.7
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.051 0.2
mRNA triptolide CTRPv2 pan-cancer AAC -0.0095 0.8
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.099 0.04
mRNA tubastatin A GDSC1000 pan-cancer AAC 0.014 0.7
mRNA valdecoxib CTRPv2 pan-cancer AAC 0.042 0.2
Download CSV